Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -45.37 Million AUD | -45.48% |
| 2023 | -31.19 Million AUD | -76.63% |
| 2022 | -18.04 Million AUD | -4220.75% |
| 2021 | -484.75 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 4.48% |
| 2024 Q4 | -17.8 Million AUD | -148.07% |
| 2024 Q2 | -21.56 Million AUD | -210.28% |
| 2024 Q1 | -8.74 Million AUD | 54.71% |
| 2024 Q3 | -7.35 Million AUD | 72.91% |
| 2023 FY | - AUD | -76.63% |
| 2023 Q3 | -7.45 Million AUD | 34.44% |
| 2023 Q1 | -4.7 Million AUD | 53.15% |
| 2023 Q4 | -19.54 Million AUD | -162.22% |
| 2023 Q2 | -11.37 Million AUD | -141.87% |
| 2022 Q4 | -10.03 Million AUD | -100.0% |
| 2022 FY | - AUD | -4220.75% |
| 2022 Q3 | -5.01 Million AUD | 27.37% |
| 2022 Q2 | -6.9 Million AUD | -100.0% |
| 2022 Q1 | -3.45 Million AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 537.341% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -3015.074% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -24.519% |
| Biome Australia Limited | -1.57 Million AUD | -2775.092% |
| Patrys Limited | -3.49 Million AUD | -1199.375% |
| Orthocell Limited | -11.68 Million AUD | -288.457% |
| Imugene Limited | -147.97 Million AUD | 69.336% |
| Noxopharm Limited | -5.94 Million AUD | -663.203% |
| PYC Therapeutics Limited | -38.11 Million AUD | -19.043% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -301.567% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -531.479% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -475.305% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -356.032% |
| CSL Limited | 4.73 Billion AUD | 100.959% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -413.702% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -1425.255% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 187.493% |
| Starpharma Holdings Limited | -12.57 Million AUD | -260.787% |
| Nanollose Limited | -1.14 Million AUD | -3852.968% |
| Memphasys Limited | -3.3 Million AUD | -1271.826% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -6198.387% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -2426.112% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -895.179% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -225.993% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -1510.159% |
| Race Oncology Limited | -14.2 Million AUD | -219.474% |
| Nyrada Inc. | -4.59 Million AUD | -887.253% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 297.58% |
| Dimerix Limited | -24.95 Million AUD | -81.806% |
| PharmAust Limited | -9.45 Million AUD | -380.084% |
| Immutep Limited | -42.87 Million AUD | -5.833% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | -1.632% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -131.847% |
| BTC Health Limited | 1.05 Million AUD | 4399.888% |
| Acrux Limited | -7.93 Million AUD | -472.137% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 122.772% |
| Biotron Limited | -5.04 Million AUD | -800.311% |
| Tissue Repair Ltd | -5.77 Million AUD | -685.735% |
| AdAlta Limited | -5.3 Million AUD | -755.718% |
| Hexima Limited | -995.54 Thousand AUD | -4457.931% |
| AnteoTech Limited | -11.57 Million AUD | -292.155% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 29.692% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -112.494% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -1299.415% |
| Actinogen Medical Limited | -12.92 Million AUD | -251.177% |
| Immuron Limited | -6.19 Million AUD | -632.777% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -2291.251% |